Conversely, in p53-null Saos2 osteosarcoma cells JMY depletion had little impact on expression (Fig. 2b), confirming that JMY enhances p53-dependent transcription during etoposide-mediated DNA damage. The gene discussed is TP53; the disease is osteosarcoma.